货号: CL-0165
Price: ¥1600 ¥1600
生长培养基: RPMI-1640[PM150110]+10% FBS[164210]+1% P/S[PB180120]
产品信息
产品名称 | NCI-H1299(人非小细胞肺癌细胞) |
别称 | H1299; H-1299; NCIH1299 |
生长特性 | 贴壁细胞 |
细胞形态 | 上皮细胞样 |
冻存条件 |
冻存液:55% 基础培养基+40% FBS+5% DMSO 温度:液氮 |
培养方案A(默认) |
生长培养基:RPMI-1640[PM150110]+10% FBS[164210]+1% P/S[PB180120] 培养条件: 气相:空气,95%;CO₂,5%, 温度:37℃ |
培养方案B(可选) |
生长培养基: 培养条件: 气相:, 温度:37℃ |
推荐传代比例 | 1:3-1:6 |
推荐换液频率 | 2-3次/周 |
参考资料(来源文献)
背景描述 | NCI-H1299细胞来源于一个淋巴结转移,患者接受了初期放疗。NCI-H1299细胞均一性的部分缺失p53蛋白,并缺少p53蛋白表达。NCI-H1299细胞可以合成0.1 pmol/毫克蛋白的NMB蛋白,而不合成促胃液释放肽(GRP)。 |
年龄(性别) | 43Y Male |
组织来源 | 肺癌:非小细胞肺癌;转移灶:淋巴结 |
细胞类型 | 肿瘤细胞 |
肿瘤类型 | 肺癌细胞 |
生物安全等级 | BSL-1 |
STR位点信息
STR鉴定图
-
USP7 deubiquitinates KRAS and promotes non-small cell lung cancer(2024)
作者:Bin Huang, Dan Cao, Xiao Yuan, Yuxian Xiong, Bingzhang Chen, Yingjie Wang, Xiaogang Niu, Ruijun Tian, Hao Huang
期刊:Cell Reports
DOI:10.1016/j.celrep.2024.114917
影响因子:7.5
引用产品: NCI-H1299 细胞, NCI-H358 细胞, NCI-H1395 细胞
-
Advancing Cancer Immunotherapy through Engineering New PD-L1 Degraders: A Comprehensive Study from Small Molecules to PD-L1-Specific Peptide–Drug Conjugates(2024)
作者:Zekun Zeng, Zhiwei Yang, Chenghao Li, Shujing Liu, Wei Wei, Ye Zhou, Simeng Wang, Mengjun Sui, Mengdan Li, Shumei Lin, Yangyang Cheng, Peng Hou
期刊:JOURNAL OF MEDICINAL CHEMISTRY
DOI:10.1021/acs.jmedchem.4c01652
影响因子:6.8
引用产品: NCI-H1299 细胞, Nthy-ori 3-1 细胞, 293T [HEK-293T] 细胞, 3T3-L1 细胞
-
Molecular Stratification and Treatment Monitoring of Lung Cancer Using a Small Extracellular Vesicle-Activated Nanocavity Architecture(2024)
作者:Junrong Li, Meiqin Li, Alain Wuethrich, Rui Guan, Lihui Zhao, Cong Hu, Matt Trau, Yao Sun
期刊:ANALYTICAL CHEMISTRY
DOI:10.1021/acs.analchem.4c00558
影响因子:6.7
引用产品: A549 [A-549] 细胞, HCC827 细胞, NCI-H1299 细胞, BEAS-2B 细胞
-
Altingia chinensis petroleum ether extract suppresses NSCLC via induction of apoptosis, attenuation of EMT, and downregulation of PI3K/Akt pathway(2024)
作者:Yiran Qin, De Zhang, Chenxin Shangguan, Chunming Xu, Shuqing Li, Yumei Li, Yang Liu, Shuping Jiang
期刊:PHYTOMEDICINE
DOI:10.1016/j.phymed.2024.156218
影响因子:6.7
-
Glutathione-dependent degradation of SMARCA2/4 for targeted lung cancer therapy with improved selectivity(2024)
作者:Ming Ji, Dehao Yu, Xinmin Liu, Luo Wang, Dongli Zhang, Zhengduo Yang, Wanqiao Huang, Heli Fan, Lulu Wang, Huabing Sun
期刊:EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
DOI:10.1016/j.ejmech.2024.116751
影响因子:6.0
引用产品: NCI-H1299 细胞, HULEC-5a 细胞
-
Molecular classification reveals the sensitivity of lung adenocarcinoma to radiotherapy and immunotherapy: multi-omics clustering based on similarity network fusion(2024)
作者:Zhang Jianguo, Li Yangyi, Dai Weijing, Tang Fang, Wang Lanqing, Wang Zhiying, Li Siqi, Ji Qian, Zhang Junhong, Liao Zhengkai, Yu Jing, Xu Yu, Gong Jun, Hu Jing, Li Jie, Guo Xiuli, He Fajian, Han Linzhi, Gong Yan, Ouyang Wen, Wang Zhihao, Xie Conghua
期刊:CANCER IMMUNOLOGY IMMUNOTHERAPY
DOI:10.1007/s00262-024-03657-x
影响因子:5.8
引用产品: A549 [A-549] 细胞, NCI-H1299 细胞
-
Multi-omics profiling and experimental verification of tertiary lymphoid structure-related genes: molecular subgroups, immune infiltration, and prognostic implications in lung adenocarcinoma(2024)
作者:Wu Sixuan, Pan Junfan, Pan Qihong, Zeng Lijun, Liang Renji, Li Yuehua
期刊:Frontiers in Immunology
DOI:10.3389/fimmu.2024.1453220
影响因子:5.7
引用产品: BEAS-2B 细胞, NCI-H1299 细胞, PC-9 细胞, HCC827 细胞, A549 [A-549] 细胞
-
Super-resolution imaging reveals the role of DDR1 cluster in NSCLC proliferation(2024)
作者:Baofeng Li, Xiao Qi, Meng Li, Peiyan Hua, Yilin Fu, Longxiang Li, Jincheng Wang, Jing Gao, Guangxin Zhang, Ti Tong, Hongda Wang
期刊:TALANTA
DOI:10.1016/j.talanta.2024.127024
影响因子:5.6
引用产品: BEAS-2B 细胞, NCI-H1299 细胞, PC-9 细胞
-
The oncogenic role and regulatory mechanism of PGK1 in human non-small cell lung cancer(2024)
作者:Tian Tian, Leng Yahui, Tang Bingbing, Dong Xiaoxia, Ren Qiulei, Liang Jingyin, Liu Tianhui, Liu Yanni, Feng Wenxiao, Liu Song, Zhou Yang, Zhao Hongyan, Shen Li
期刊:Biology Direct
DOI:10.1186/s13062-023-00448-9
影响因子:5.5
-
Targeted liposomes for macrophages-mediated pulmonary fibrosis therapy(2024)
作者:Wang Yujie, Zhao Fang, Wang Xiangyu, Zuo Haojie, Ru Yiming, Cao Xi, Wang Yang
期刊:Drug Delivery and Translational Research
DOI:10.1007/s13346-023-01508-3
影响因子:5.4
引用产品: RAW 264.7 细胞, NCI-H1299 细胞
-
Q1:为什么我看的文献里的细胞培养条件和你们官网的培养条件不一样呢?
部分细胞是会出现多种培养条件的,我们公司优先选择引种来源的培养条件以及建系者所用培养条件,出现差异的原因是不同实验室在保藏过程中更改了细胞的培养条件,为了避免细胞突然更换培养条件后不适应,建议您优先使用厂家推荐的培养条件培养。

识别码示意图